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Background:  The benefits of early abciximab administration and thrombus aspiration in patients with ST-elevation myocardial infarction (STEMI) 
undergoing primary percutaneous intervention (PPCI) have been elaborated in previous studies. However, whether there is an adjunctive effect of 
thrombus aspiration among STEMI patients, with angiographic evidence of thrombus, receiving early abciximab prior to hospital arrival remains 
unclear.
Methods:  In the context of a fixed protocol for PPCI, 158 patients with STEMI were enrolled, in whom abciximab was started early before arrival at 
the hospital (in-ambulance); 79 patients had PPCI without thrombus aspiration (Conventional PCI group), and 79 had PPCI with thrombus aspiration 
(thrombectomy facilitated PCI group). The primary end point was ST-segment resolution at 90 min. Secondary endpoints included enzymatic infarct 
size as well as LVEF assessed by Gated-SPECT. Major adverse cardiac events (MACE) were evaluated up to 12 months.
Results:  The 2 groups were matched for baseline clinical and angiographic characteristics. The rate of complete ST-segment resolution at 90 
minutes was significantly higher in the thrombectomy facilitated group (p=0.002), and multivariable logistic regression analysis identified only 
thrombectomy as an independent predictor of ST-segment resolution (odds ratio= 6.7, 95% CI = 2.4-18.4, p< 0.001). No difference was observed 
between both groups in enzymatic infarct size assessed by peak CK (p=0.8), and peak Tn-T levels (p=0.5). Also the LVEF at 3-months was similar 
(p=0.9). At 12 month clinical follow-up, thrombus aspiration was however associated with reduced all-cause mortality (log-rank p= 0.03).
Conclusions:  Among STEMI patients treated with PPCI and early (in-ambulance) abciximab, the adjunctive use of manual thrombectomy 
significantly improves post-procedural ST-segment resolution, and mortality at 12 months follow-up.
